Resolute Capital Asset Partners LLC

Q2 2026 13F-HR Holdings

Location
Denver, CO
Holdings as of
6/30/2026
Date filed
8/14/2026
Form type
13F-HR
Num holdings
48
Total value ($000)
$234,088
Net value change ($000)
+44,005 (23.2%)
New positions
25
Sold out positions
18
Turnover %
81.7%
Sector allocation + QoQ delta (equities-only)
Prev filing: 5/15/2026 Next filing: — SEC filing

Snapshot: Change Analysis

Compared to Q1 2026
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
Ascendis Pharma AS 31,640 NEW
ARGX 11,133 NEW
SPOT 8,035 NEW
LEGN 7,534 NEW
AGYS 6,793 NEW
AMZN 5,957 83.3%
QCOM 5,544 NEW
VERSIGENT LIMITED 5,041 NEW
NOVT 4,867 NEW
BA 4,329 NEW
Top Reduces (Value $000, Stocks/ETFs)
ASND -22,559 -100.0%
NVDA -6,104 -100.0%
UTHR -5,930 -100.0%
CEG -5,585 -100.0%
SCHW -5,220 -65.3%
CVX -5,173 -100.0%
TPL -4,442 -36.7%
ARM -4,236 -100.0%
DELL -4,103 -100.0%
CRS -3,942 -100.0%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type